Two Sigma Advisers’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
VVA
EC
5VM
FCM
AVLSA
IC
BCM
Two Sigma Advisers's TECX Position: Q3 2024 in Review
Two Sigma Advisers sold out of Tectonic Therapeutic (TECX) in Q3 2024, closing a stake of 13,071 shares — an estimated $215K sold.
Two Sigma Advisers first reported a position in TECX in Q2 2020 and held it in 17 quarters. The position peaked at $1.59M in Q4 2021. 53 funds tracked by Wall St. Rank hold TECX as of Q3 2024.
- Two Sigma Advisers reported no remaining Tectonic Therapeutic position as of Q3 2024 after selling out during the quarter.
- Two Sigma Advisers sold 13,071 Tectonic Therapeutic shares in Q3 2024, an estimated $215K.
- Two Sigma Advisers first reported a position in Tectonic Therapeutic in Q2 2020 and held it in 17 quarters.
- Two Sigma Advisers's Tectonic Therapeutic position peaked at $1.59M in Q4 2021.
- 53 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2024.
Based on Two Sigma Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.